Key Metrics
9.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.96
5-Year SI
5-year SI
- N/A 2-year SI
- 0.93 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
1.27
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cellular oncology (Dordrecht) ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
- 15 Dec 23
- Cellular Oncology
-
Full paper
DNA repair in tumor radioresistance: insights from fruit flies genetics
- 14 Dec 23
- Cellular Oncology
-
Full paper
CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells
- 20 Nov 23
- Cellular Oncology
-
Full paper
Retraction Note: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling
- 30 Oct 23
- Cellular Oncology
-
Full paper
FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination
- 2 Oct 23
- Cellular Oncology
-
Full paper
Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour
- 22 Aug 23
- Cellular Oncology
Scite analysis
Powered by scite_
0.9k articles received 14.2k citations see all
- 631 Supporting
- 13,402 Mentioning
- 44 Contrasting
Editorial notices
- 7 Retractions
- 0 Withdrawals
- 18 Corrections
- 24 Errata
- 0 Expression of Concern
FAQs
How long has Cellular oncology (Dordrecht) been actively publishing?
Cellular oncology (Dordrecht) has been in operation since 1989 till date.
What is the publishing frequency of Cellular oncology (Dordrecht) ?
Cellular oncology (Dordrecht) published with a Bi-monthly frequency.
How many articles did Cellular oncology (Dordrecht) publish last years ?
In 2023, Cellular oncology (Dordrecht) published 27 articles.
What is the eISSN & pISSN for Cellular oncology (Dordrecht) ?
For Cellular oncology (Dordrecht),eISSN is 2211-3436 and pISSN is2211-3428.
What is Citescore for Cellular oncology (Dordrecht) ?
Citescore for Cellular oncology (Dordrecht) is 9.7.
What is SNIP score for Cellular oncology (Dordrecht) ?
SNIP score for Cellular oncology (Dordrecht) is 1.27.
Who is the publisher of Cellular oncology (Dordrecht) ?
SPRINGER is the publisher of Cellular oncology (Dordrecht).